Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- · 60d
- Not stated
- Not stated
- Aug 31, 2026
Official announcement on grants_gov · opens the funder's page. Always confirm dates there.
Other topics in this solicitation
Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
$750k
Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
$2.2M
Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)
Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
$1.5M
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
$500k
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
$1M
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
$750k
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- The scoring framework for this mechanism — we have not extracted per-criterion detail for this specific announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)
$350k
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k
More in metabolic
Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
$1.8M
Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
$1.5M
Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
$2.2M